Heska Corporation Announces Financial Results for the Second Quarter of Fiscal 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, today announced financial results for the second quarter ended June 30, 2013.

Heska Corporation (NASDAQ:HSKA - News; “Heska” or the “Company”), a provider of advanced veterinary diagnostic and other specialty veterinary products, today reported financial results for its second quarter ended June 30, 2013. The Company previously announced the acquisition of 54.6% of Cuattro Vet US, LLC (“Cuattro Vet USA”), which was subsequently renamed Heska Imaging US, LLC, and this acquisition is reflected in Heska’s consolidated financial results for the second quarter of 2013 with no contribution in the second quarter last year.

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC